RxDoctor Payments Data

Alexander Nguyen, APRN

Nurse Practitioner · Annandale, VANPI 1235846213

Payments from drug & device makers

$3,876in general payments, 2019–2025

Across 192 payments — averaging $20.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$477
  • Lilly USA, LLC$432
  • Pfizer$357
  • AstraZeneca$349
  • Boehringer Ingelheim$335
  • Bayer$324
  • plus $2K from 18 others

What the payments were for

  • Food & beverage$3,876100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,876 in reported general payments places this provider in the 95th percentile of 2,166 nurse practitioner providers in Virginia.

See all nurse practitioner providers in Virginia

Medicare billing

Part B allowed, 2024
$1,835
Medicare patients
17
Services billed
20

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol58$63,667
OzempicSemaglutide19$32,089
JardianceEmpagliflozin22$25,850
JanuviaSitagliptin Phosphate33$25,351
TradjentaLinagliptin16$19,730
EliquisApixaban13$13,432
MyrbetriqMirabegron23$10,846
Rosuvastatin Calcium110$2,411
Diclofenac Sodium29$1,664
SynthroidLevothyroxine Sodium18$1,480
Atorvastatin Calcium147$1,403
Ezetimibe41$911
Omeprazole68$897
Losartan Potassium98$837
Metformin Hcl78$790

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$349$63,66758 claims
Boehringer IngelheimJardiance, Tradjenta$335$45,58038 claims
Novo NordiskOzempic$477$32,08919 claims
PfizerEliquis$357$13,43213 claims
Astellas Pharma US IncMyrbetriq$34$10,84623 claims
AbbVieSynthroid$119$1,48018 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,166 nurse practitioner providers in Virginia.

Other nurse practitioner in Annandale

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →